John Liuzzo, MD, PhD

Original Contribution

Prospective, Randomized, Placebo-Controlled Evaluation of Esomeprazole in Coronary Artery Disease Patients. EPAC: Esomeprazole Prevention of Atypical Chest Pains

05/26/2011

John T. Coppola , MD, FACC, FSCAI;

Ravikiran Korabathina , MD;

John A. Ambrose , MD;

John Liuzzo , MD, PhD;

Sajal Das , MD;

Mary Devoe , RN;

Saurabh Agarwal , MD;

Srmiti Deshmukh , MD;

ABSTRACT: Background. Coronary artery disease (CAD) patients experience chest pain (CP) from cardiac and non-cardiac etiologies. Objective. Proton pump inhibitor (PPI) treatment of CAD patients with atypical CP would result in less CP, as...

ABSTRACT: Background. Coronary...

05/26/2011

Journal of Invasive Cardiology

Review

Simultaneous Papillary Muscle Avulsion and Free Wall Rupture during Acute Myocardial Infarction. Intra-Aortic Balloon Pump: A Br

08/01/2008

John T. Coppola , MD, FACC, FSCAI;

John Liuzzo , MD, PhD;

Yong T. Shin , MD;

Christopher Choi , MD;

Sanjaykumar Patel , MD;

Robert Braff , MD;

Cardiogenic shock complicates 7% of acute myocardial infarctions (AMI) in patients presenting to hospitals, with a concomitant mortality rate of 70%.1 In the age of reperfusion therapy, significant improvement in reducing this adverse outcome...

Cardiogenic shock complicates 7%...

08/01/2008

Journal of Invasive Cardiology

Review

Sirolimus- and Taxol-eluting Stents Differ Towards Intimal Hyperplasia and Re-endothelialization

08/01/2008

John A. Ambrose , MD;

John T. Coppola , MD, FACC, FSCAI;

John Liuzzo , MD, PhD;

In-stent restenosis of coronary arteries is the major reason for the recurrence of occlusion after successful percutaneous coronary intervention (PCI) and occurs in 20–50% of patients.1 The development of in-stent restenosis depends on...

In-stent restenosis of coronary...

08/01/2008

Journal of Invasive Cardiology